JCO OP Special Series: Disparities in Cancer Care for Hispanic-Latinx People
JCO Oncology Practice is now accepting manuscripts for a special issue on disparities in cancer care for Hispanic-Latinx people.
Submit your manuscript today at https://www.editorialmanager.com/op-ascopubs/default.aspx
Guest Editors Miguel Villalona-Calero, MD; Gilberto Lopes, MD, MBA; Narjust Duma, MD; and Pelin Cinar, MD, are soliciting papers from all oncology professionals about disparities in genomics, cancer-related access, care, toxicities, social determinants, costs, health economics, and clinical outcomes for Hispanic-Latinx Americans. We understand that Hispanic-Latinx people are not a single race but an ethnicity.
Miguel Villalona-Calero, MD
Gilberto Lopes, MD, MBA
Narjust Duma, MD
Pelin Cinar, MD
This special issue will have six primary areas of focus: Border health and care; immigration and cancer care; access to health and state differences; rural cancer care for the Hispanic-Latinx people; economics of cancer care for Hispanic-Latinx people; and workforce diversity, including trainee pipeline and leadership.
Papers may address any aspect of cancer care, including screening, survivorship, and end of life with associated frameworks and successful models for improving cancer care delivery and work force, generalizable scientific quality improvement projects, cancer care policy, or the business of oncology for Hispanic-Latinx Americans. We will prioritize papers that inform practices about validated approaches to reduce disparities in this population or subpopulations with specific challenges. However, we will not prioritize papers that only demonstrate disparities without a study of potential interventions. This special issue will also include a clinical review of racial disparities in cancer care and commentaries discussing how to promote health equity and address disparities for Hispanic-Latinx people.
Suggested topics include studies that show impacts to address:
- Social determinants of health and their impact on disease, response, and outcomes
- Health system access and specific barriers to care
- Implicit bias and privilege in cancer care
- Border health and care
- Immigration and cancer care (disease types and treatment impacts, accessing care, and impacts to cancer outcomes, as examples)
- Rural care for Hispanic-Latinx people
- Economics of cancer care for Hispanic-Latinx people (impacts to outcomes for Hispanic-Latinx people based on systems with different access/coverage/service availabilities, for example)
- Impact of structural racism on cancer care for Hispanic-Latinx patients
- Criminal justice as it relates to cancer care in correctional health-care systems as well as the disproportionate engagement of Hispanic-Latinx patients with the criminal justice system and the impact that has on navigating/managing cancer care
- Social justice disparities and their impact on cancer care for Hispanic-Latinx Americans (eg, disparities in economic, political, and social opportunities)
- Health literacy for Hispanic-Latinx Americans and communication strategies for the oncology care team
- Models of care that address disparities, including successes that reduce the disparities for -Hispanic-Latinx Americans
- Clinical trial design, recruitment, enrollment, and access
- Myths of racial differences that should not impact cancer care decisions
- Unique issues in the assessment and management of cancer-related toxicities
- Workforce diversity issues (eg, lack of Hispanic-Latinx members of the oncology care team, medical, academic, and political leadership)
- Trust (lack of) in cancer care
- Disparities in genomic profile and ancestry
- Language barriers and access to care
- Cultural issues as they relate to obesity, diet, and nutrition
- Intimacy and relationship issues
- Advanced care planning/end of life/hospice care/survivorship.
We request manuscript submissions by January 15, 2022, for this Spring 2022 Special Issue.
For editorial inquiries and potential publication suitability, contact the JCO OP editorial office at jcoop@asco.org.
© 2021. American Society of Clinical Oncology. All rights reserved.
